HGF and renal carcinoma: Future research should further elucidate the molecular mechanisms underpinning the role of the HGF/c‐Met pathway in renal cancer initiation and progression and explore safer and more effective c‐Met inhibitors, ultimately providing innovative strategies for the precision treatment of renal cancer.